ConcertAI Integrates ASCO Guidelines into AI Precision Suite

Jun 2, 2025
ConcertAI has integrated ASCO Guidelines into its AI Precision Suite and CancerLinQ SmartLinQ solutions, enhancing oncology care recommendations. The integration, powered by CARAai, will provide guideline-concordant care recommendations to oncologists and biopharma researchers.
ConcertAI Integrates ASCO Guidelines into AI Precision Suite

ConcertAI has integrated the American Society of Clinical Oncology (ASCO) Guidelines into its AI-driven Precision Suite and CancerLinQ SmartLinQ solutions, announced in a press release. This integration, powered by the CARAai platform, aims to provide guideline-concordant care recommendations to medical oncologists within the CancerLinQ Network and biopharma researchers using Precision Explorer and Trials.

The integration allows biopharma researchers to assess guideline-concordant care and outcomes, while oncologists using SmartLinQ solutions will receive ASCO Guideline-concordant recommendations for patient treatment options. This enhancement is part of ConcertAI's ongoing efforts to optimize patient outcomes by providing comprehensive treatment options.

The ASCO Guidelines will be available within these solutions by June 30th, facilitating the assessment of guideline-concordant care across various settings and informing clinical trial design. The CancerLinQ SmartLinQ deployment of these guidelines will be showcased at the 2025 ASCO Annual Meeting in Chicago.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.